NCT01725230View on ClinicalTrials.gov

Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Fostamatinib

100-mg tablet

DRUG

Rosuvastatin

20-mg tablet

DRUG

Simvastatin

40-mg tablet

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY